Graham Capital Management’s Fate Therapeutics FATE Stock Holding History

Graham Capital Management’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$95.9K	Sell
2025 Q1	$111K	Buy
2024 Q4	$36.9K	Buy
2024 Q3	–	Sell
2024 Q2	$37.9K	Buy
2023 Q4	–	Sell
2023 Q3	$46K	Sell
2023 Q2	$678K	Buy